Form 4: Acadia Healthcare CEO Christopher H. Hunter Reports Acquisition of Common Stock

Sentiment:

SEC Form 4


Christopher H. Hunter, CEO of Acadia Healthcare Company, Inc., reports acquiring common stock through grants that vest over time.

Summary

  • Christopher H. Hunter, the CEO of Acadia Healthcare Company, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On May 5, 2025, Hunter acquired 115,818 shares of common stock that will vest over a 3-year period in equal yearly installments beginning May 5, 2026.
  • Additionally, Hunter acquired 18,781 shares of common stock that will vest on May 5, 2028.
  • Both transactions were acquisitions (A) at a price of $0.
  • Following these transactions, Hunter beneficially owns 265,883 shares of Acadia Healthcare Company, Inc. common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing. The CEO increasing their stake is mildly positive, suggesting confidence, but it's not a major event.

Positives

  • The CEO's acquisition of shares could be interpreted positively, signaling confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules imply a multi-year commitment from the CEO.

Industry Context

Form 4 filings are routine disclosures, but they are closely watched by investors for insights into management's perspective on the company's value and future prospects. CEO stock ownership is generally viewed as a positive sign.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
  • The vesting schedules are typical for executive equity grants, encouraging long-term commitment.
  • Comparing the size of the grant to those of CEOs at comparable healthcare companies would provide further context.

Stakeholder Impact

  • Shareholders may view the CEO's increased stock ownership as a positive signal.
  • The vesting schedule incentivizes the CEO to focus on long-term value creation.

Key Dates

DateDescription
05/05/2025Date of stock acquisition.
05/05/2026First vesting date for 115,818 shares.
05/05/2028Vesting date for 18,781 shares.
05/07/2025Date of Form 4 filing.

Keywords

Acadia Healthcare, ACHC, Form 4, Beneficial Ownership, Christopher H. Hunter, CEO, Stock Acquisition, Vesting Shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.